[Lifeline, A Musical That Raises The Alarm On Antimicrobial Resistance](https://wbbsec.com/opinions-and-features/lifeline-a-musical-that-raises-the-alarm-on-antimicrobial-resistance/)
[Lifeline, A Musical That Raises The Alarm On Antimicrobial Resistance](https://wbbsec.com/opinions-and-features/lifeline-a-musical-that-raises-the-alarm-on-antimicrobial-resistance/)
In: Press Releases

PDF: 2.1.2013 WBB Sponors 2013 BIO CEO

WBB Sponsors the 2013 BIO CEO & Investor Conference

Conference is focused on established and emerging publicly traded and select private biotech companies

For Immediate Release

February 1, 2013

SAN DIEGO, CAWBB Securities is a sponsor of The 15th Annual Bio CEO & Investor Conference on February 11 and 12, 2013 in New York City. The Bio CEO & Investor Conference is one of largest investor conferences and focuses on both established and emerging publicly traded biotech companies. The conference features company presentations, fireside chats, panel discussions and one-on-one chats. It is held annually at the Waldorf Astoria hotel in New York City.

About WBB Securities

WBB Securities is a leading investment management, investment banking, and equity research firm.  Established in 2001 and headquartered in San Diego, California, WBB Securities is a registered independent broker dealer and investment advisor with proprietary trading desks that have market-making capabilities.  WBB Securities has built a nationwide team of respected senior investment and research professionals with a network of branches throughout the US serving institutional and high net worth clients.  The firm also maintains an investment banking and equity research practice focused exclusively in the life sciences niche.  www.wbbsec.com

About BIO CEO & Investor Conference

The BIO CEO & Investor Conference, now in its sixteenth year, is an annual conference that provides a forum for institutional investors, industry analysts, biotechnology executives are provided with an opportunity meet with and learn about established and emerging biotechnology companies.

The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.